Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Healthcare
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is... see more

Recent & Breaking News (CSE:RVV)

Revive Therapeutics to Pursue the Psychedelic Market With Agreement and Investment in Red Light Holland Financing

GlobeNewswire February 10, 2020

Revive Therapeutics Announces Offering of $210,000 of Convertible Debenture Units

GlobeNewswire February 5, 2020

Revive Therapeutics Provides Update on its Cannabinoid Program Initiatives for Drug Delivery and in the Prevention of Ischemia and Reperfusion Injury from Organ Transplantation

GlobeNewswire January 20, 2020

Revive Therapeutics Provides Update on its Clinical Development Plan For Rare Liver Diseases

GlobeNewswire January 6, 2020

Revive Therapeutics Announces Grant of Stock Options

GlobeNewswire December 27, 2019

Revive Therapeutics Provides Update on its Cannabis-based Pharmaceutical Initiatives

GlobeNewswire December 19, 2019

Revive Therapeutics Announces New Leadership Appointment and Board Change

GlobeNewswire December 18, 2019

Revive Therapeutics Announces Results for the Three Months Ended September 30, 2019

GlobeNewswire November 27, 2019

Revive Therapeutics Announces Joint Venture with Herman Holdings for the Production of Cannabis Derivative Products in Canada

GlobeNewswire November 14, 2019

Revive Therapeutics Announces Non-Binding Letter of Intent to Acquire Greeninsightz Limited and Brokered Private Placement

GlobeNewswire November 12, 2019

Revive Therapeutics Ltd. Announces Results for Fiscal Year Ended June 30, 2019

GlobeNewswire October 24, 2019

Revive Therapeutics and Herman Holdings Enter Into Non-Binding Letter of Intent to Merge

GlobeNewswire October 17, 2019

CSE New Listing - Revive Therapeutics Commences Trading on the Canadian Securities Exchange - Video News Alert on Investmentpitch.com

Newsfile July 24, 2019

Revive Therapeutics Announces Approval of CSE Listing and Delisting from TSX-V

GlobeNewswire July 19, 2019

Revive Therapeutics Announces Cannabis Product Derivative Manufacturing and Development Facility

GlobeNewswire June 20, 2019

Revive Therapeutics Announces Results for the Three and Nine Months Ended March 31, 2019

GlobeNewswire May 30, 2019

Revive Therapeutics Announces United States Patent Grant for Cannabinoid Delivery System

GlobeNewswire April 17, 2019

Revive Therapeutics Announces Collaboration and Royalty Agreement With Richmond Cannabis Co.

GlobeNewswire April 11, 2019

Revive Therapeutics Announces Results for the Three and Six Months Ended December 31, 2018

GlobeNewswire February 28, 2019

Revive Closes Over 1.4 Million in Non-Brokered Private Placement

GlobeNewswire February 11, 2019